Speaker: Prof. Farhad Hafezi, ELZA Institute
Meeting: AOPA: Association des ophtalmologues privés algériens
Date: March 26, 2021
Language: Français
Summary: Le Pr Hafezi de l’institut ELZA en Suisse parle du cross-linking dans les cornées ultrafines. Nouveau protocôle publié dans le prestigieux “American Journal of Ophthalmology” et implémenté dans la machine C-eye.
Speaker: Prof. Farhad Hafezi, ELZA Institute
Meeting: Hellenic Society for Intraocular Implants and Refractive Surgery (HSIOIRS)
Date: March 2021
Language: English
Summary: Prof. Hafez gives on overview about the current state of CXL technology at the annual Hellenic HSOIRS meeting 2021
Speaker: Prof. Farhad Hafezi, ELZA Institute
Meeting: CSO Italia Webinar. Innovative Ophthalmology
Date: February 2021
Language: English
Summary: Prof. Farhad Hafezi from the ELZA Institute in Switzerland explains corneal cross-linking for keratoconus and keratitis at the slit lamp.
Speaker: Prof. Farhad Hafezi. ELZA Institute.
Meeting: CSO Italia webinar on emerging new technologies
Date: February 2021
Language: English
Summary: International webinar, organized by CSO Italia, to highlight new developments in the field of anterior segment diagnostics and treatment.
Speaker: Prof. Farhad Hafezi, ELZA Institute
Meeting: Al Qassimi International Conference, UAE
Date: February 2021
Language: English
Summary: Keratoglobus was the only remaining ectatic corneal disease that could not be treated – until now: the sub400m protocol allows for cross-linking in ultrathin corneas.
Speaker: Dr. Emilio Torres, University of Zurich, Switzerland
Meeting: Annual Meeting of the Brazilian Society for Cataract and Refractive Surgery (BRASCRS) 2020
Date: December 2020
Language: English
Summary: Dr. Torres gives a brief overview about the different steps in a CXL procedure at the slit lamp.
Speaker: Prof. Farhad Hafezi. ELZA Institute.
Meeting: Annual Meeting of the Delhi Ophthalmological Society
Date: December 2020
Language: English
Summary Annual meeting of the Delhi Ophthalmological Society. For more information, see here: http://dosonline.org/
